Lv3
230 积分 2023-11-19 加入
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
14天前
已完结
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
14天前
已完结
Targeting THR-β for MASLD Treatment: Current Progression and Emerging Prospects
14天前
已完结
Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery
19天前
已完结
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
21天前
已完结
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
21天前
已完结
Current status and future trends of the global burden of MASLD
21天前
已完结
Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials
21天前
已完结
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
27天前
已完结
Discovery of a selective CDK7 PROTAC against acute leukemia with low platelet toxicity
1个月前
已完结
皖公网安备34019202002308
